47 Stock and 53 ETF Enanta Pharmaceuticals (ENTA) alternatives
The most close Enanta Pharmaceuticals (ENTA) alternative is ETF HRTS (TEMA HEART & HEALTH ETF). The correlation is 0.6776.
Stocks that highly correlated with ENTA
| Symbol | Name | Market cap | Sector | Industry | Correlation |
|---|---|---|---|---|---|
| FLD | Fold Holdings Inc - Class A | $23M | Financial Services | Capital Markets | 0.67 |
| SION | Sionna Therapeutics Inc | $2B | Healthcare | Biotechnology | 0.66 |
| FLX | BingEx Ltd | $271M | Industrials | Integrated Freight & Logistics | 0.65 |
| OFSSO | OFS Capital Corp | $341M | N/A | N/A | 0.61 |
| YOUL | Youlife Group Inc | $41M | Consumer Defensive | Education & Training Services | 0.59 |
| GECCH | Great Elm Capital Corp | $350M | N/A | N/A | 0.59 |
| NWTG | Newton Golf Company | $4.59M | Consumer Cyclical | Leisure | 0.58 |
| PHOE | Phoenix Asia Holdings Ltd | $492M | Industrials | Engineering & Construction | 0.57 |
| SUGP | SU Group Holdings Ltd - Class A | $5.51M | Industrials | Security & Protection Services | 0.57 |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $674M | Healthcare | Biotechnology | 0.57 |
| TMUSI | TMobile US Inc 5.500 Senior Notes due June 2070 | $23B | N/A | N/A | 0.56 |
| CICB | CION Investment Corporation 7.50 Notes due 2029 | $1.26B | N/A | N/A | 0.56 |
| CV | CapsoVision Inc | $315M | Healthcare | Medical Devices | 0.55 |
| PLT | N/A | $508M | N/A | N/A | 0.55 |
| BIOA | BioAge Labs Inc | $1.01B | Healthcare | Drug Manufacturers - Specialty & Generic | 0.55 |
| NUTR | Nusatrip Inc | $174M | Consumer Cyclical | Travel Services | 0.54 |
| BON | Bon Natural Life Ltd - Class A | $4.72M | Basic Materials | Specialty Chemicals | 0.54 |
| KYTX | Kyverna Therapeutics Inc | $471M | Healthcare | Biotechnology | 0.54 |
| KYMR | Kymera Therapeutics Inc | $9.38B | Healthcare | Biotechnology | 0.54 |
| THH | TryHard Holdings Ltd | $12M | Industrials | Specialty Business Services | 0.53 |
| DAIC | CID HoldCo Inc | $40M | Technology | Information Technology Services | 0.53 |
| NEE-P-T | NextEra Energy Inc 7.234 Corporate Units | $106B | N/A | N/A | 0.53 |
| RYOJ | rYojbaba Co. Ltd | $51M | Industrials | Consulting Services | 0.53 |
| CAMP | CAMP4 Therapeutics Corp | $219M | Healthcare | Biotechnology | 0.53 |
| MIAX | Miami International Holdings Inc | $4B | Financial Services | Capital Markets | 0.52 |
| AARD | Aardvark Therapeutics Inc | $146M | Healthcare | Biotechnology | 0.52 |
| NPACU | New Providence Acquisition Corp III - Units (1 Ord Share Class A & 1/3 War) | $68M | Financial Services | Shell Companies | 0.52 |
| GSRTU | GSR III Acquisition Corp - Units (1 Ord Class A & 1/7 Rts) | $467M | N/A | N/A | 0.52 |
| MSIF | MSC Income Fund Inc | $515M | Financial Services | Asset Management | 0.51 |
| PACS | PACS Group Inc | $7.07B | Healthcare | Medical Care Facilities | 0.51 |
| MEKA | MELI Kaszek Pioneer Corp - Class A | $297M | N/A | N/A | 0.51 |
| ORIQU | Origin Investment Corp I - Units (1 Ord Cls & 1/2 War) | $22M | Financial Services | Shell Companies | 0.51 |
| WYTC | Wytec International Inc | $14M | Communications Equipment | Information Technology | 0.51 |
| HERZ | Herzfeld Credit Income Fund Inc Com | $230M | Financial Services | Asset Management | 0.50 |
| ZBIO | Zenas Biopharma Inc | $1.83B | Healthcare | Biotechnology | 0.50 |
| SARO | StandardAero Inc | $9.15B | Industrials | Aerospace & Defense | 0.50 |
| LIMN | Liminatus Pharma Inc | $5.14M | Healthcare | Biotechnology | 0.50 |
| SLRN | Acelyrin Inc | $229M | Healthcare | Biotechnology | 0.50 |
| TIXT | TELUS International (Cda) Inc (Sub Voting) | $1.20B | Technology | Software - Infrastructure | 0.50 |
| LHAI | Linkhome Holdings Inc | $19M | Real Estate | Real Estate Services | 0.50 |
| WCT | Wellchange Holdings Co. Ltd | $3.28M | Technology | Software - Application | 0.50 |
| EFTY | Etoiles Capital Group Co Ltd - Class A | $287M | Industrials | Consulting Services | 0.49 |
| ADCT | Adc Therapeutics SA | $163M | Healthcare | Drug Manufacturers - Specialty & Generic | 0.49 |
| PYPD | Polypid Ltd | $95M | Healthcare | Biotechnology | 0.49 |
| WRD | WeRide Inc | $2.11B | Technology | Software - Application | 0.49 |
| VYLD | J P Morgan Chase & Co Inverse VIX ShortTerm Futures ETNs due March 22 2045 | $81B | N/A | N/A | 0.49 |
| RANGR | Range Capital Acquisition Corp | $1.20M | N/A | N/A | 0.49 |